Stock listing

KLRA Stock Price, News, Filings & Events — Kailera Therapeutics, Inc.

Selected listing: KLRA · BOATS · USD · US

This page tracks Kailera Therapeutics, Inc.'s KLRA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KLRA:BOATS. KLRA:BOATS is the stock-level entry point for investors researching Kailera Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kailera Therapeutics, Inc. (ticker: KLRA) is a public company based in the United States with a market capitalization of approximately $2.4 billion. The company focuses on developing innovative therapies to address unmet medical needs. Kailera is committed to advancing its research and development efforts to improve patient outcomes.

KLRA:BOATSUSDUSUpdated September 12, 2026
Kailera Therapeutics, Inc. logo
Ticker
KLRA:BOATS
Asset type
Stock
Market cap
$1.81B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Kailera Therapeutics, Inc. KLRA:BOATS stock context

This page tracks Kailera Therapeutics, Inc.'s KLRA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KLRA:BOATS. KLRA:BOATS is the stock-level entry point for investors researching Kailera Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kailera Therapeutics, Inc. (ticker: KLRA) is a public company based in the United States with a market capitalization of approximately $2.4 billion. The company focuses on developing innovative therapies to address unmet medical needs. Kailera is committed to advancing its research and development efforts to improve patient outcomes.

Latest news from Kailera Therapeutics, Inc.

All Kailera Therapeutics, Inc. news →

Research Kailera Therapeutics, Inc.

Alternate listings